Abstract
Introduction
In patients with diabetes, persistent hyperglycemia causes chemical changes in serum components, increasing the incidence of various complications such as skin wounds. To better understand glucose-associated chemical stress on serum components, this study explores small-molecule nutrients to protect human dermal fibroblasts (HDFs) from glucose-rich, chemically deteriorated culture conditions.
Methods
Various cell culture media with different concentrations of glucose and various test compounds were subjected to heat treatment as a chemically accelerated model of serum deterioration. The heat-treated and non-heat-treated media were compared to each other in terms of the content of glycation products and their effects on cell viability and wound healing in vitro.
Results
There was no difference in the content of glycation products or their effects on cell viability between the non-heat-treated low-glucose (LG, 5.5 mm) and high-glucose (HG, 50 mm) media that were not heat treated. However, the heat-treated HG media had a higher content of glycation products and decreased cell viability compared to the heat-treated LG media. Of the 20 free amino acids, 20 amidated amino acids and various antioxidants derived from cysteine (Cys) or ascorbic acid (AA) added to the media, followed by heat treatment, only cysteinamide (C-NH2) enhanced the viability and wound healing of HDFs cultured in the heat-treated HG media. C-NH2 reduced glycation of serum proteins while forming its own glycation products, suggesting a competitive interaction with glucose-derived reactions.
Conclusion
These findings provide proof-of-concept evidence that C-NH2 can protect serum components and improve fibroblast-associated wound closure under chemically stressed, glucose-rich conditions. Further studies using physiologically relevant models are required to evaluate its biological and translational significance.
Keywords: Diabetes mellitus, Hyperglycemia, High glucose, Glycation, Advanced glycation end products, Cysteinamide, N-acetyl cysteinamide, Human dermal fibroblasts, Wound healing
Introduction
Diabetes mellitus is a chronic metabolic disease in which blood glucose concentration remains above a certain physiological level [1]. Blood contains various types of cells and biochemical components, such as proteins, lipids, carbohydrates, amino acids, vitamins, and metal ions, and oxygen concentration is maintained within a certain range [2]. If high blood glucose concentrations persist for a long period, glycation of various blood components occurs significantly [3]. In particular, the aldehyde group of sugars undergoes a Maillard reaction with the primary amine groups of proteins, free amino acids, vitamins, and lipids in the blood to form a Schiff base and generate Amadori products [4]. The glycation process involves multiple oxidative reactions, leading to the formation of advanced glycation end products (AGEs) [5, 6]. The AGEs increase oxidative stress and the receptor-mediated inflammatory responses in cells, making normal cell survival difficult, worsening diabetes, and causing vascular damage and tissue dysfunction [3, 7].
Active research is being conducted to develop treatments for suppressing the glycation of blood components caused by high glucose concentrations and enhancing cell survival under diabetic conditions [8–10]. Aminoguanidine (AGD) and pyridoxamine (PYM), which are known to inhibit the production of AGEs from the reaction between proteins and glucose, ameliorate retinopathy in animal models of diabetes [11, 12]. Cytotoxicity of AGEs is attenuated by several antioxidants, such as N-acetyl cysteine (NAC) and glutathione (GSH) [13, 14]. These previous studies suggest that competitive glycation inhibitors or antioxidants have a high potential to prevent and treat diabetes and its complications. Patients with diabetes are prone to various skin complications due to the effects of protein glycation and other diabetes-related factors [15, 16]. These conditions lead to delayed wound healing and accelerated skin aging [17–19]. However, safe and effective prevention and treatment methods for these symptoms remain to be developed.
The present study aims to explore small-molecule nutrients to inhibit the glucose-derived glycation of serum components and to enhance the viability of human dermal fibroblasts (HDFs) in diabetes-mimicking conditions. First, various free and amidated amino acids were screened because they have a high potential as competitive inhibitors for protein glycation by glucose [20]. The amidated amino acids were included because our previous studies have observed that they exhibit similar or different biological activities to the free forms [21–23]. Second, cysteine (Cys), ascorbic acid (AA), and their derivatives were screened as representative antioxidants with different biochemical activities [22, 24, 25]. The results from this study highlight the unique action of cysteinamide (C-NH2) in preventing the deterioration of serum components from high-glucose-derived reactions.
Methods
Reagents
Glucose, mannitol, fructose, sucrose, NaCl, NAC, GSH, N-acetyl cysteinamide (NAC-NH2), AA, ascorbyl 2-O-glucoside (AG), and 20 different free amino acids, including Cys, were purchased from Sigma-Aldrich (St. Louis, MO, USA). The 20 different amidated amino acids, including C-NH2, were purchased from Watanabe Chemical Industries, Ltd. (Hiroshima, Japan). This study used 20 free forms and 20 amidated forms of amino acids (Table 1). Magnesium ascorbyl 2-phosphate (MAP) and ascorbyl tetraisopalmitate (ATI) were purchased from Biosynth Carbosynth (Berkshire, UK). 3-O-ethyl ascorbic acid (EAA) and AGD were purchased from TCI Chemicals (Tokyo, Japan). 3-(4,5-dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium bromide (MTT) was purchased from Amresco (Solon, OH, USA). Dimethyl sulfoxide (DMSO) was purchased from AppliChem GmbH (Darmstadt, Germany). PYM was purchased from MedChemExpress (New Jersey, USA).
Table 1.
Free amino acids and amidated amino acids used in this study
| Free amino acids | Triple-letter codes | Amidated amino acids | Single-letter codes |
|---|---|---|---|
| Alanine | Ala | Alaninamide | A-NH2 |
| Cysteine | Cys | Cysteinamide | C-NH2 |
| Aspartic acid | Asp | Aspartic acid α-amide | D-NH2 |
| Glutamic acid | Glu | Glutamic acid α-amide | E-NH2 |
| Phenylalanine | Phe | Phenylalaninamide | F-NH2 |
| Glycine | Gly | Glycinamide | G-NH2 |
| Histidine | His | Histidinamide | H-NH2 |
| Isoleucine | Ile | Isoleucinamide | I-NH2 |
| Lysine | Lys | Lysinamide | K-NH2 |
| Leucine | Leu | Leucinamide | L-NH2 |
| Methionine | Met | Methioninamide | M-NH2 |
| Asparagine | Asn | Asparaginamide | N-NH2 |
| Proline | Pro | Prolinamide | P-NH2 |
| Glutamine | Gln | Glutaminamide | Q-NH2 |
| Arginine | Arg | Argininamide | R-NH2 |
| Serine | Ser | Serinamide | S-NH2 |
| Threonine | Thr | Threoninamide | T-NH2 |
| Valine | Val | Valinamide | V-NH2 |
| Tryptophan | Trp | Tryptophanamide | W-NH2 |
| Tyrosine | Tyr | Tyrosinamide | Y-NH2 |
Cell Culture Media
A growth medium used in maintaining HDFs was DMEM, low glucose (5.5 mm), supplemented with 1% antibiotics (100 U mL−1 penicillin, 0.1 mg mL−1 streptomycin, 0.25 μg mL−1 amphotericin B) (Thermo Fisher Scientific, Waltham, MA, USA), and 10% fetal bovine serum (FBS) (Gibco BRL, Grand Island, NY, USA). This study also used various culture media with different compositions (Table 2). In addition to the low-glucose (LG) media containing 5.5 mm glucose and the high-glucose (HG) media containing 50 mm glucose, other media were prepared by adding 44.5 mm mannitol, 44.5 mm fructose, 44.5 mm sucrose, or 22.5 mm NaCl to the LG media. These media were supplemented with 10% or 0.5% FBS. In some experiments, a test compound (0.5 or 1.0 mm) or vehicle was added to the LG or HG medium. For heat treatment, the 3-mL portions of these media were placed in 15-mL conical tubes, capped, and incubated at 60°C for 72 h. The media were cooled and stored in the refrigerator until used in the experiments.
Table 2.
Composition of the cell culture media used in this study
| | LG | HG | LG + mannitol | LG + fructose | LG + sucrose | LG + NaCl |
|---|---|---|---|---|---|---|
| Glucose | 5.5 mm | 50 mm | 5.5 mm | 5.5 mm | 5.5 mm | 5.5 mm |
| Mannitol | | | 44.5 mm | | | |
| Fructose | | | | 44.5 mm | | |
| Sucrose | | | | | 44.5 mm | |
| NaCl | | | | | | 22.25 mm |
LG, low glucose; HG, high glucose.
Determination of Fluorescent Glycation Products
The content of glycation products in the media was quantified by a fluorimetric method using an AGEs assay kit (ab273298) obtained from Abcam Limited (Cambridge, UK). A 2.5-µL portion of different media was diluted to 100 µL with wash buffer II/AGEs assay buffer and measured by fluorescence (Ex/Em = 360/460 nm) at 25°C in an endpoint mode using a Gemini EM fluorescence microplate reader (Molecular Devices, Sunnyvale, CA, USA). A calibration curve was created using positive control AGE protein. The amount of glycation products was expressed as AGE equivalents (mg mL−1).
In some experiments, the content of the fluorescent glycation products in the protein and non-protein fractions of the media was determined separately. A 50-µL portion of different media was mixed with 100 µL of ice-cold 20% trichloroacetic acid solution in an Eppendorf tube and incubated on ice for 10 min to precipitate proteins, followed by centrifugation at 14,500 g for 15 min. The pellet was washed with 200 µL of ice-cold isopropanol 3 times, dried, and dissolved in 50 µL of 6 m guanidine solution with heating at 50°C for 1 h. A 2.5-µL portion of this solution was diluted to 100 µL with the wash buffer II/AGEs assay and used in determining the content of fluorescent glycation products of the protein fraction. A 7.5-µL portion of the supernatant from the centrifugation was diluted to 100 µL with the wash buffer II/AGEs assay to 100 µL and used in determining the content of the fluorescent glycation products of the non-protein fraction.
Thin Layer Chromatography
Samples (5 µL) of the media were applied to a silica-coated thin-layer chromatography (TLC) plate (Merck, Darmstadt, Germany). Ascending TLC was run using a mixture of n-propanol, ammonia, and water (6∶2∶2, v/v/v) as a mobile phase in an airtight container. The TLC plate was viewed under an ultraviolet (UV) lamp to detect fluorescent compounds and then exposed to iodine vapor to visualize redox-sensitive compounds.
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis
Samples (24 µL) of test media were mixed with 5× Laemmli sample buffer containing 0.25 m Tris-Cl, pH 6.8, 50% glycerol, 10% sodium dodecyl sulfate (SDS), 0.5 m dithiothreitol, and 0.25% bromphenol blue (Biosesang Inc., Gyeonggi-do, Republic of Korea) and heat treated at 95°C for 5 min. The samples were resolved on a 10% polyacrylamide gel containing 0.1% SDS with ExcelBand™ Enhanced 3-color protein marker (SMOBIO Technology, Inc., Hsinchu City, Taiwan). After running SDS-polyacrylamide gel electrophoresis (SDS-PAGE) at 100 V, the gel was fixed in a mixture of ethanol, acetic acid, and water (5:1:4, v/v/v) and stained with 0.1% Coomassie Brilliant Blue R-250 (Sigma-Aldrich) in a solution of methanol, acetic acid, and water (5:1:4, v/v/v) for 1 h, followed by destaining in a solution of methanol, acetic acid, and water (4:1:5, v/v/v) 3 times.
Cell Viability Assay
HDFs derived from adult skin were obtained from Cascade Biologics (Portland, OR, USA) and cultured with a growth medium in a closed incubator at 37°C in humidified air containing 5% CO2. In each experiment, cells were seeded in a 96-well plate at a density of 1,000 or 500 cells per well and cultured in 100 μL per well of a growth medium for 24 h, and the growth medium was replaced with a medium of interest, followed by additional incubation for 48 h. The viability of the adherent cells was assessed by a colorimetric MTT assay.
In vitro Scratch Assay
The effects of test compounds on wound healing were examined using an in vitro scratch assay [26]. Cells were seeded in a 6-well plate (2 × 105 cells per well) and cultured with 2 mL of a growth medium for 24 h. The confluent cell monolayer was scratched in a straight line using a sterilized 1-mL pipette tip to create a wound with a constant width. After aspirating the cultured medium, cells were washed once with PBS to remove cell debris and treated with a medium of interest, followed by additional incubation for up to 72 h. Images of cells around wounds were captured at 24-h intervals using a phase-contrast microscope (Eclipse TS100, Nikon Instruments Inc., Melville, NY, USA). Wound areas in the microscopic cell images were analyzed using the NIH ImageJ program (NIH – https://rsb.info.nih.gov/ij). Data are presented as wound healing (%) calculated using the following equation: Wound healing (%) = [(A0 – At)/A0] × 100%, where A0 is the area of the original wound, and At is the area of the wound after a specified incubation time.
Statistical Analysis
SigmaStat v.3.11 Statistical Analysis Software (Systat Software Inc., San Jose, CA, USA) was used in the statistical analysis of experimental data. Data are presented as the mean ± standard deviation. A one-way ANOVA at a p < 0.05 level was performed to determine the existence of different group means among all experimental groups, followed by Duncan’s multiple range tests to compare all experimental groups to each other at a p < 0.05 level.
Results
Comparison of Various Cell Culture Media
The first experiment compared the effects of various cell culture media, such as LG, HG, LG + mannitol, LG + fructose, LG + sucrose, and LG + NaCl media containing 10% or 0.1% FBS, on the viability of HDFs seeded at a density of 1,000 or 500 cells per well in 96-well plates (Fig. 1a, b). The viability of cells seeded at a density of 1,000 cells per well was higher in the media containing 10% FBS than in the media containing 0.5% FBS, and there was no difference between the media containing the same concentration of FBS, even if their sugar or salt compositions were different. Similar trends were observed with the cells seeded at a density of 500 cells per well.
Fig. 1.

Comparison of various cell culture media. Human dermal fibroblasts (HDFs) were seeded in 96-well plates at a density of 1,000 (a, c) or 500 (b, d) cells per well and cultured for 48 h with low glucose (LG), high glucose (HG), or other media containing 10% or 0.5% fetal bovine serum (FBS), that had been non-heat-treated (a, b) or heat-treated (c, d) at 60°C for 72 h. Cell viability was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, with results presented as optical density (OD) at 570 nm. Statistical significance between experimental groups was determined at p < 0.05, with different lowercase letters indicating significant differences.
Various culture media were heat treated at 60°C for 72 h to mimic long-term chemical changes of the cell culture media. The heat treatment of media caused an overall decrease in the viability of cells seeded at a density of 1,000 cells or 500 cells per well (Fig. 1c, d). Among the heat-treated media containing 10% FBS, the HG and LG + fructose media caused a greater decrease in the viability of cells seeded at a density of 1,000 cells per well than the LG and other media. There was no difference in cell viability among the heat-treated media containing 0.5% FBS with different sugar or salt compositions. Similar trends were observed with the cells seeded at a density of 500 cells per well. These results suggest that cell culture medium components have a greater effect on cell viability when they undergo chemical changes due to heat treatment.
Effects of Heat Treatment on Cell Culture Media
The content of fluorescent glycation products was compared among the non-heat-treated and heat-treated cell culture media containing 10% or 0.5% FBS. There was no difference in the content of fluorescent glycation products among the non-heat-treated media containing 10% FBS; however, the content increased in the heat-treated media containing 10% FBS, especially in HG and LG + fructose media (Fig. 2a). Similar trends were observed with the non-heat-treated and heat-treated media containing 0.5% FBS, although the changes were relatively smaller (Fig. 2b).
Fig. 2.

Effects of heat treatment on culture media. The LG, HG, and other media containing 10% or 0.5% FBS were non-heat-treated or heat-treated at 60°C for 72 h. The content of fluorescent glycation products is presented as advanced glycation end-product (AGE) equivalents (mg mL−1) (a, b). HDFs were seeded in 96-well plates at a density of 1,000 cells per well and cultured for 48 h with different media. Cell viability assessed by the MTT assay is presented as OD at 570 nm (c, d). Different lowercase letters indicate significant differences between experimental groups at p < 0.05.
The effects of the non-heat-treated and heat-treated cell culture media containing 10% or 0.5% FBS on cell viability were compared. There was no difference in cell viability among the non-heat-treated media containing 10% FBS; however, the heat-treated HG and LG + fructose media decreased cell viability significantly compared to other heat-treated media (Fig. 2c). There was no difference in cell viability among the non-heat-treated media containing 0.5% FBS and among the heat-treated media containing 0.5% FBS (Fig. 2d). These results suggest that the heat-accelerated reactions of reducing sugars, i.e., glucose and fructose, with serum components generate fluorescent glycation products and deteriorate cell culture media.
Effects of Free Amino Acids and Amidated Amino Acids
The effects of 20 free amino acids and 20 amidated amino acids were compared. The test compounds were added to the LG or HG media containing 10% FBS, followed by heat treatment. Different free amino acids and amidated amino acids had variable effects on the content of the fluorescent glycation products in the heat-treated LG and HG media containing 10% FBS (Fig. 3a, c). In particular, methioninamide (M-NH2), histidinamide (H-NH2), prolinamide (P-NH2), C-NH2, histidine (His), and alanine (Ala) increased the fluorescent glycation products in both heat-treated LG and HG media. These results show that some amidated or free amino acids participate in the glycation reaction and generate their own fluorescent glycation products.
Fig. 3.

Effects of free amino acids and amidated amino acids. The test compounds were added at 1.0 mm to LG or HG media containing 10% FBS followed by heat treatment at 60°C for 72 h. The content of fluorescent glycation products in these media is presented as AGE equivalents (mg mL−1) (a, c). The viability of HDFs was assessed as in Figure 2 and presented as OD at 570 nm (b, d). Different lowercase letters indicate significant differences between experimental groups at p < 0.05.
When comparing the viability of cells in the heat-treated LG and HG media supplemented with each amino acid, it was discovered that only C-NH2 enhanced the viability of cells cultured in the heat-treated HG media (Fig. 3b, d). The other 19 amidated amino acids and 20 free amino acids had no effects. In the heat-treated LG media, all 20 free amino acids and 20 amidated amino acids, including C-NH2, did not affect cell viability. These results suggest that C-NH2 can prevent the deterioration of HG media most effectively among 20 free amino acids and 20 amidated amino acids.
Effects of Antioxidants
The effects of C-NH2 and other compounds with antioxidant properties, such as Cys, NAC, GSH, AA, MAP, EAA, AG, and ATI, were compared. Of these compounds, only C-NH2 increased the content of fluorescent glycation products at 0.5 or 1.0 mm in the heat-treated LG and HG media (Fig. 4a, c). Cys, NAC, GSH, AA, MAP, EAA, AG, and ATI had no remarkable effects. In addition, only C-NH2 enhanced the viability of cells cultured in the heat-treated HG media, not LG media (Fig. 4b, d). ATI decreased cell viability, and other test compounds had no remarkable effects on cell viability. These results further support the unique properties of C-NH2, preventing the deterioration of HG media.
Fig. 4.

Effects of antioxidants. Cysteine (Cys), cysteinamide (C-NH2), N-acetyl cysteine (NAC), glutathione (GSH), ascorbic acid (AA), magnesium ascorbyl 2-phosphate (MAP), 3-O-ethyl ascorbic acid (EAA), ascorbyl 2-O-glucoside (AG), or ascorbyl tetraisopalmitate (ATI) was added at 0.5 and 1.0 mm to the LG or HG media containing 10% FBS followed by heat treatment at 60°C for 72 h. The content of fluorescent glycation products in the media is presented as AGE equivalents (mg mL−1) (a, c). The viability of HDFs was assessed as in Figure 2 and presented as OD at 570 nm (b, d). Different lowercase letters indicate significant differences between experimental groups at p < 0.05.
C-NH2 Is a Competitive Glycation Inhibitor
A potential mechanism for “the HG medium deterioration-preventing action” of C-NH2 is proposed. C-NH2 may play a role as a competitive glycation inhibitor that blocks the glucose-derived glycation of serum components while generating its own glycation products (Fig. 5a). When the effects of Cys and C-NH2 were compared in the total heat-treated LG and HG media with or without FBS, only C-NH2 increased the fluorescence intensity of the total media more highly in the HG media and in the absence of FBS (Fig. 5b). When each medium was separated into the protein and non-protein fractions, C-NH2 decreased the fluorescence intensity of the protein fraction of HG media, and conversely, serum decreased the fluorescence intensity of the non-protein fraction of HG media (Fig. 5c, d). TLC analysis of reaction products showed that C-NH2 in HG media reacted with glucose to generate fluorescent glycation products, which were inhibited by FBS (Fig. 5e). FBS components in HG media also reacted with glucose to generate other fluorescent glycation products, which were inhibited by C-NH2. These pieces of evidence support the proposed mechanism of action of C-NH2 as a competitive glycation inhibitor, mitigating the glycation of serum proteins and other components.
Fig. 5.

A proposed mechanism of action of C-NH2 as a competitive glycation inhibitor and supporting evidence. It is hypothesized that C-NH2 may act as a competitive glycation inhibitor that blocks the glucose-derived glycation of serum components while generating its own glycation products (a). Cys or C-NH2 was added at 1.0 mm to the LG or HG media with or without 10% FBS followed by heat treatment at 60°C for 72 h. The content of fluorescent glycation products in the total medium (b), protein fraction (c), and non-protein fraction (d) is presented as AGE equivalents (mg mL−1). Different lowercase letters indicate significant differences between experimental groups at p < 0.05. The medium samples were resolved by thin-layer chromatography (TLC) and the plate was viewed under ultraviolet (UV) light or visualized by exposing it to iodine vapor (e). Major fluorescent glycation products derived from C-NH2 or serum components are indicated.
Effects of Cys and C-NH2 on the Glycation of Serum Proteins
Since protein glycation by glucose results in an increase in size [27], SDS-PAGE was utilized to analyze the glycation of serum proteins. Samples of the non-heat-treated or heat-treated LG and HG media supplemented with Cys, C-NH2, or vehicle were subjected to SDS-PAGE (Fig. 6). In the non-heat-treated medium samples, several distinct protein bands, including a major band of albumin (66 kDa), were visible; however, many of these bands disappeared, diffused, or relocated in the heat-treated medium samples. The aggregated proteins with increased size and decreased mobility appeared in the stacking gel and the upper part of the separating gel. Among the newly emerged protein bands in the heat-treated media, the 80-kDa protein band attracted attention as its intensity increased with glucose concentrations and was decreased by C-NH2 and Cys in the order. This protein band is considered to be useful as a surrogate marker of glycation of serum proteins.
Fig. 6.

Effects of Cys and C-NH2 on the glycation of serum proteins. The LG and HG media containing 10% FBS were supplemented with Cys or C-NH2 at 1.0 mm, followed by heat treatment at 60°C for 72 h or not. The non-heat-treated and heat-treated medium samples were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) to monitor the changes in the size of major proteins due to glycation. The molecular weights (kDa) of protein markers are indicated on the left side.
C-NH2, but Not Cys, Promotes the Wound Healing of HDF Monolayers
The wound healing of HDF monolayers exposed to the non-heat-treated or heat-treated LG or HG media supplemented with Cys, C-NH2, or vehicle was compared in an in vitro scratch assay (Fig. 7a, b). Wound healing of HDF monolayers in the non-heat-treated LG and HG media progressed at a similar rate and slowed down in the heat-treated LG and HG media, being the slowest in the heat-treated HG media. Cys transiently and weakly promoted early wound healing (24 h) of HDF monolayers in the heat-treated LG and HG media but enlarged the wound at a later time point (72 h) compared to the vehicle control. In contrast, C-NH2 consistently promoted wound healing of HDF monolayers in the heat-treated LG and HG media to a greater extent at all measured time points (24, 48, and 72 h).
Fig. 7.

C-NH2, but not Cys, promotes the wound healing of HDF monolayers in an in vitro scratch assay. Various media were prepared as in Fig. 6. After creating a scratch wound, HDF monolayers were cultured with the heat-treated LG and HG media. Wound healing was assessed at 24-h intervals. Representative images of cell monolayers around scratch wounds are seen (a). Data are presented as wound healing (%) of the original scratches (b). Different lowercase letters indicate significant differences between experimental groups at p < 0.05.
Comparison of C-NH2, NAC-NH2, AGD, and PYM
Additional experiments compared C-NH2 with well-known glycation inhibitors, AGD and PYM. NAC-NH2, a hydrophobic derivative of C-NH2, was also included in these experiments. PYM emitted fluorescence on its own in the non-heat-treated medium, and the increment in the content of fluorescent glycation products in the heat-treated medium was similar to that in the control (Fig. 8a). The effects of NAC-NH2 on the content of fluorescent glycation products in the heat-treated media were either absent or minimal. AGD slightly decreased the content of fluorescent glycation products in the heat-treated LG and HG media compared to the control. When each medium was separated into the protein and non-protein fractions, AGD and PYM decreased the content of fluorescent glycation products in the protein fraction with unclear effects on the non-protein fraction (Fig. 8b, c).
Fig. 8.

Comparison of C-NH2, NAC-NH2, AGD, and PYM. The LG and HG media containing 10% FBS were supplemented with C-NH2, N-acetyl cysteinamide (NAC-NH2), aminoguanidine (AGD), or pyridoxamine (PYM) at 1.0 mm, followed by heat treatment at 60°C for 72 h or not. The content of fluorescent glycation products in the total medium (a), protein fraction (b), and non-protein fraction (c) of the non-heat-treated and heat-treated media is presented as AGE equivalents (mg mL−1). The viability of HDFs was assessed as in Figure 2 and presented as OD at 570 nm (d). Different lowercase letters indicate significant differences between experimental groups at p < 0.05.
The effects of NAC-NH2 on the content of fluorescent glycation products in the protein fraction were either absent or smaller compared to C-HN2. When comparing their effects on cell viability, NAC-NH2 enhanced the viability of cells cultured in the heat-treated HG media similar to C-NH2, whereas AGD and PYM had no such effects (Fig. 8d). These results suggest that C-NH2 and NAC-NH2 can prevent the deterioration of HG media more effectively than AGD and PYM.
Discussion
This study employed a chemically accelerated in vitro model to examine glucose-associated deterioration of serum-containing culture media, rather than directly mimicking diabetic conditions in vivo. In contrast to conventional glycation models that incubate a single protein with glucose under physiological temperature for extended periods [28–31], the present approach applied prolonged heat treatment to complete culture media to accelerate chemical reactions involving glucose and serum components. It should be noted that such heat exposure is expected to induce multiple biochemical and structural alterations beyond glycation alone, including protein denaturation and the loss of bioactive factors. Therefore, the observed cellular responses likely reflect the combined effects of glucose-derived reactions and heat-induced serum modification.
Can we prevent the deterioration of the medium by using small-molecule nutrients? This study, which explored various amino acids and antioxidants, supported the feasibility of this strategy. Among the 20 free amino acids and 20 amidated amino acids, only C-NH2 prevented the deterioration of the HG media by heat treatment. Similar effects were not observed for chemically related antioxidants, such as Cys, NAC, and GSH, nor were they for other antioxidants, such as AA, MAP, EAA, AG, and ATI. Additionally, NAC-NH2 showed similar effects to C-NH2, but well-known glycation inhibitors, AGD and PYM, did not. Therefore, C-NH2 and NAC-NH2 have distinct properties that can help prevent the deterioration of serum components by glucose-derived reactions.
The proposed mechanism underlying the protective action of C-NH2 is based on its competitive participation in glucose-derived chemical reactions. Supporting this interpretation, C-NH2 reduced glycation of serum proteins while forming fluorescent glycation products itself. However, this interpretation should be regarded as a working hypothesis rather than a definitive mechanism. Alternative or additional mechanisms, including preservation of serum bioactivity or mitigation of heat-induced damage, cannot be excluded based on the present data. Further studies will be required to delineate the precise molecular basis for the unique activity of C-NH2.
Despite the structural and chemical similarities between C-NH2 and Cys, only C-NH2 enhanced cell viability and promoted wound healing of HDFs in the heat-treated HG media. It suggests that minor structural and chemical differences in small molecules can lead to large differences in biological outcomes. It has been reported that the Maillard reaction between Cys and glucose produces various compounds, such as 2,4-dihydroxy-2,5-dimethyl-3(2H)-thiophenone and pyrrolothiazolate [32, 33], but no previous study investigated a similar topic for C-NH2. Further studies are needed to compare the glycation reaction products derived from C-NH2 and Cys and their biological effects on cells.
Although C-NH2 consistently promoted wound closure in the scratch assay, this observation is limited to fibroblast-associated migration and proliferation in a two-dimensional monolayer system. This simplified model does not recapitulate the three-dimensional architecture, extracellular matrix remodeling, or multicellular interactions involved in physiological wound healing. Accordingly, conclusions regarding wound healing are restricted to fibroblast-associated effects observed in this in vitro system.
From a future perspective, validation of C-NH2 activity in more physiologically relevant systems will be important. In particular, three-dimensional skin equivalents or organotypic culture models may better capture the complex tissue architecture and extracellular environment involved in skin wound repair. In terms of potential application, C-NH2 could be explored in local topical formulations, such as wound dressings or skin preparations, where direct interaction with extracellular fluids may be advantageous. Systemic supplementation may also be considered due to its small-molecule nature; however, pharmacokinetics, bioavailability, and safety must be carefully evaluated in vivo. At present, these possibilities remain speculative and require further experimental validation.
“The HG medium deterioration-preventing action” observed only with C-NH2 and NAC-NH2, but not with Cys and NAC, suggests an important role of the amide group common to the former two compounds. However, the presence of the amide group is not considered a sufficient condition for this action because other amidated amino acids did not show a similar action. It seems that the action of C-NH2 and NAC-NH2 is provided by a free sulfhydryl group in addition to the amide group. It is also expected that the action will be maintained even when the α-amine group of C-NH2 is modified by various substituents because NAC-NH2 has a similar action to C-NH2.
Deterioration of the medium involves the loss of existing cell survival components and the production of new cytotoxic components. We suppose these components may include protein and non-protein factors. It is known that specific amino acid residues in a protein are preferentially glycated, and the reaction is affected by the distribution of surrounding amino acid residues [34]. Studying the biological consequences associated with specific chemical changes of certain factors affected by glucose-derived reactions will contribute to the identification of new molecular targets, with high physiological and pathological relevance, for treating diabetic complications.
The content of fluorescent glycation products in the heat-treated media was not always negatively correlated with cell viability. In the media containing 10% FBS, the higher the glycation product content, the lower the cell viability. However, in the media containing 0.1% FBS, cell viability was independent of glycation product content. AGD and PYM decreased protein glycation content in the media but did not improve cell viability. NAC-NH2 improved cell viability without affecting protein glycation content in the media. These observations suggest that cell survival and function can change independently of the glycation of medium components.
In previous studies, Cys prevented glucose-induced protein glycation in vitro, and Cys-supplemented drinking water reduced AGEs and various other risk factors for diabetic complications in diabetic atherosclerotic rats [35]. NAC and S-allyl cysteine prevented the protein glycation by methylglyoxal, glyoxal, or fructose in vitro and enhanced the viability of HT22 cells exposed to a mixture of BSA and methylglyoxal, with NAC being more potent [36]. Topical application of AGD improved inflammation and pathological changes in the skin of diabetic rats [37]. However, AGD failed to promote skin wound healing and even delayed it in db/db mice [38]. In light of the results of the current study, C-NH2 and NAC-NH2 may provide better treatment options for diabetic complications than Cys, NAC, or AGD. Future in vivo experiments using animal models are warranted to compare their therapeutic efficacy for diabetic skin wounds.
In conclusion, this study demonstrates that C-NH2 and NAC-NH2 can effectively attenuate glucose-associated deterioration of serum-containing culture media and enhance fibroblast survival and wound closure under chemically stressed, glucose-rich conditions. These findings provide proof-of-concept evidence for the unique protective properties of amidated Cys derivatives in this experimental system. Future studies using three-dimensional skin models and in vivo systems will be necessary to evaluate their physiological relevance and therapeutic potential.
Statement of Ethics
An ethics statement was not required for this study type since no human or animal subjects or materials were used.
Conflict of Interest Statement
The authors declare no conflicts of interest.
Funding Sources
This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (Grant No. RS-2024-00437643).
Author Contributions
Conceptualization: Y.C.B. and W.J.L. Investigation: J.Y.C. Supervision: Y.C.B. Writing – original draft preparation: J.Y.C. and Y.C.B. Writing – review and editing: N.G.H. and W.J.L. Project administration: N.G.H. Funding acquisition: W.J.L., Y.C.B., and N.G.H. All authors have read and agreed to the published version of the manuscript.
Funding Statement
This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (Grant No. RS-2024-00437643).
Data Availability Statement
All data generated or analyzed during this study are included in this article. Further inquiries can be directed to the corresponding authors.
References
- 1. Ojo OA, Ibrahim HS, Rotimi DE, Ogunlakin AD, Ojo AB. Diabetes mellitus: from molecular mechanism to pathophysiology and pharmacology. Med Novel Tech Devices. 2023;19:100247. [Google Scholar]
- 2. Poletaev A. Composition of the blood and reflection of the health state of human body. Biomedical and. Biomed Pharmacol J. 2018;11(4):1797–800. [Google Scholar]
- 3. Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol. 2014;18(1):1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Zhang Q, Ames JM, Smith RD, Baynes JW, Metz TO. A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease. J Proteome Res. 2009;8(2):754–69. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Twarda-Clapa A, Olczak A, Białkowska AM, Koziołkiewicz M. Advanced glycation end-products (AGEs): formation, chemistry, classification, receptors, and diseases related to AGEs. Cells. 2022;11(8):1312. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Uceda AB, Mariño L, Casasnovas R, Adrover M. An overview on glycation: molecular mechanisms, impact on proteins, pathogenesis, and inhibition. Biophys Rev. 2024;16(2):189–218. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Perrone A, Giovino A, Benny J, Martinelli F. Advanced glycation end products (AGEs): Biochemistry, signaling, analytical methods, and epigenetic effects. Oxid Med Cell Longev. 2020;2020:3818196. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Sarmah S, Roy AS. A review on prevention of glycation of proteins: potential therapeutic substances to mitigate the severity of diabetes complications. Int J Biol Macromol. 2022;195:565–88. [DOI] [PubMed] [Google Scholar]
- 9. Fournet M, Bonté F, Desmoulière A. Glycation damage: a possible hub for major pathophysiological disorders and aging. Aging Dis. 2018;9(5):880–900. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Bansal S, Burman A, Tripathi AK. Advanced glycation end products: key mediator and therapeutic target of cardiovascular complications in diabetes. World J Diabetes. 2023;14(8):1146–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Hammes HP, Strödter D, Weiss A, Bretzel RG, Federlin K, Brownlee M. Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model. Diabetologia. 1995;38(6):656–60. [DOI] [PubMed] [Google Scholar]
- 12. Stitt A, Gardiner TA, Alderson NL, Canning P, Frizzell N, Duffy N, et al. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes. 2002;51(9):2826–32. [DOI] [PubMed] [Google Scholar]
- 13. Loske C, Neumann A, Cunningham AM, Nichol K, Schinzel R, Riederer P, et al. Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. J Neural Transm. 1998;105(8–9):1005–15. [DOI] [PubMed] [Google Scholar]
- 14. Kuzan A. Toxicity of advanced glycation end products (Review). Biomed Rep. 2021;14(5):46. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Chen C-Y, Zhang J-Q, Li L, Guo M-M, He Y-F, Dong Y-M, et al. Advanced glycation end products in the skin: molecular mechanisms, methods of measurement, and inhibitory pathways. Front Med. 2022;9:837222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. David P, Singh S, Ankar R. A comprehensive overview of skin complications in diabetes and their prevention. Cureus. 2023;15(5):e38961. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Dasari N, Jiang A, Skochdopole A, Chung J, Reece EM, Vorstenbosch J, et al. Updates in diabetic wound healing, inflammation, and scarring. Semin Plast Surg. 2021;35(3):153–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Park HY, Kim JH, Jung M, Chung CH, Hasham R, Park CS, et al. A long-standing hyperglycaemic condition impairs skin barrier by accelerating skin ageing process. Exp Dermatol. 2011;20(12):969–74. [DOI] [PubMed] [Google Scholar]
- 19. Choi JY, Ha NG, Lee WJ, Boo YC. Synthetic and natural agents targeting advanced glycation end-products for skin anti-aging: a comprehensive review of experimental and clinical studies. Antioxidants. 2025;14(4):498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Chilukuri H, Kulkarni MJ, Fernandes M. Revisiting amino acids and peptides as anti-glycation agents. Medchemcomm. 2018;9(4):614–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Kim JH, Seok JK, Kim YM, Boo YC. Identification of small peptides and glycinamide that inhibit melanin synthesis using a positional scanning synthetic peptide combinatorial library. Br J Dermatol. 2019;181(1):128–37. [DOI] [PubMed] [Google Scholar]
- 22. Lee HK, Ha JW, Hwang YJ, Boo YC. Identification of L-Cysteinamide as a potent inhibitor of tyrosinase-mediated dopachrome formation and eumelanin synthesis. Antioxidants. 2021;10(8):1202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Ha JW, Choi JY, Boo YC. Differential effects of histidine and histidinamide versus cysteine and cysteinamide on copper ion-induced oxidative stress and cytotoxicity in HaCaT keratinocytes. Antioxidants. 2023;12(4):801. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Lee JE, Boo YC. Combination of glycinamide and ascorbic acid synergistically promotes collagen production and wound healing in human dermal fibroblasts. Biomedicines. 2022;10(5):1029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Choi JY, Ha JW, Boo YC. Multifaceted effects of L-Cysteine, L-Ascorbic acid, and their derivatives on the viability and melanin synthesis of B16/F10 cells under different conditions. Antioxidants. 2024;13(3):330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration. Nat Protoc. 2007;2(2):329–33. [DOI] [PubMed] [Google Scholar]
- 27. Shen CY, Wu CH, Lu CH, Kuo YM, Li KJ, Hsieh SC, et al. Advanced glycation end products of bovine serum albumin suppressed Th1/Th2 cytokine but enhanced monocyte IL-6 gene expression via MAPK-ERK and MyD88 transduced NF-κB p50 signaling pathways. Molecules. 2019;24(13):2461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Imai Y, Nakashima Y, Kanno T. Inhibitory effects of Parachlorella Beijerinckii extracts on the formation of advanced glycation end products and glycative stress-induced inflammation in an in vitro skin dermis-like model. Evid Based Complement Alternat Med. 2022;2022:8789903. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Fernandes MF, Conegundes JLM, Pinto NDC, de Oliveira LG, de Aguiar JAK, Souza-Fagundes EM, et al. Cecropia pachystachya leaves present potential to be used as new ingredient for antiaging dermocosmetics. Evid Based Complement Alternat Med. 2019;2019:8263934. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Spagnuolo L, Della Posta S, Fanali C, Dugo L, De Gara L. Antioxidant and antiglycation effects of polyphenol compounds extracted from hazelnut skin on advanced glycation end-products (AGEs) formation. Antioxidants. 2021;10(3):424. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Drouet S, Leclerc EA, Garros L, Tungmunnithum D, Kabra A, Abbasi BH, et al. A green ultrasound-assisted extraction optimization of the natural antioxidant and anti-aging Flavonolignans from milk thistle Silybum marianum (L.) gaertn. Fruits for cosmetic applications. Antioxidants. 2019;8(8):304. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Noda K, Terasawa N, Murata M. Formation scheme and antioxidant activity of a novel Maillard pigment, pyrrolothiazolate, formed from cysteine and glucose. Food Funct. 2016;7(6):2551–6. [DOI] [PubMed] [Google Scholar]
- 33. Shu CK, Hagedorn ML, Mookherjee BD, Ho CT. Two novel 2-hydroxy-3(2H)-thiophenones from the reaction between cystine and 2,5-dimethyl-4-hydroxy-3(2H)-furanone. J Agric Food Chem. 1985;33(4):638–41. [Google Scholar]
- 34. Sun FX, Suttapitugsakul S, Xiao HP, Wu RH. Comprehensive analysis of protein glycation reveals its potential impacts on protein degradation and gene expression in human cells. J Am Soc Mass Spectrom. 2019;30(12):2480–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Mahdavifard S, Bathaie SZ, Nakhjavani M, Heidarzadeh H. L-cysteine is a potent inhibitor of protein glycation on both albumin and LDL, and prevents the diabetic complications in diabetic-atherosclerotic rat. Food Res Int. 2014;62:909–16. [Google Scholar]
- 36. Bhattacharya R, Saini S, Ghosh S, Roy P, Ali N, Parvez MK, et al. Organosulfurs, S-allyl cysteine and N-acetyl cysteine sequester di-carbonyls and reduces carbonyl stress in HT22 cells. Sci Rep. 2023;13(1):13071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Tian M, Qing C, Niu Y, Dong J, Cao X, Song F, et al. Aminoguanidine cream ameliorates skin tissue microenvironment in diabetic rats. Arch Med Sci. 2016;12(1):179–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Berdal M, Jenssen T. Effects of AGE inhibition with aminoguanidine in a diabetic db/db mouse wound model. J Diabetes Mellit. 2014;04(02):107–14. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All data generated or analyzed during this study are included in this article. Further inquiries can be directed to the corresponding authors.
